drugset / Trial / NCT02578719

Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up

NCT02578719 ↗

Phase 4 Withdrawn Bozok University
RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluates effectiveness of greater occipital nerve blocks with bupivacaine compared to placebo in chronic migraine patients.

Timeline

Start
2016-07
Primary completion
2018-07
Completion
2018-07

Outcome

Outcome not reported

Stopped: “Local Drug Authority didn't give permission to start.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Other

Indications